APOE and Alzheimer's disease: from lipid transport to physiopathology and therapeutics

MA Husain, B Laurent, M Plourde - Frontiers in neuroscience, 2021 - frontiersin.org
Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by
extracellular amyloid β (Aβ) and intraneuronal tau protein aggregations. One risk factor for …

A quarter century of APOE and Alzheimer's disease: progress to date and the path forward

ME Belloy, V Napolioni, MD Greicius - Neuron, 2019 - cell.com
Alzheimer's disease (AD) is considered a polygenic disorder. This view is clouded, however,
by lingering uncertainty over how to treat the quasi" monogenic" role of apolipoprotein E …

Global estimates on the number of persons across the Alzheimer's disease continuum

A Gustavsson, N Norton, T Fast, L Frölich… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Global estimates on numbers of persons in early stages of Alzheimer's disease
(AD), including prodromal and preclinical, are lacking, yet are needed to inform policy …

Frequency of LATE neuropathologic change across the spectrum of Alzheimer's disease neuropathology: Combined data from 13 community-based or population …

PT Nelson, C Brayne, ME Flanagan, EL Abner… - Acta …, 2022 - Springer
Limbic-predominant age-related TDP-43 encephalopathy neuropathologic change (LATE-
NC) and Alzheimer's disease neuropathologic change (ADNC) are each associated with …

Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition

L Mosconi, V Berti, J Dyke, E Schelbaum, S Jett… - Scientific reports, 2021 - nature.com
All women undergo the menopause transition (MT), a neuro-endocrinological process that
impacts aging trajectories of multiple organ systems including brain. The MT occurs over …

Amyloid precursor protein processing and Alzheimer's disease

RJ O'brien, PC Wong - Annual review of neuroscience, 2011 - annualreviews.org
Alzheimer's disease (AD), the leading cause of dementia worldwide, is characterized by the
accumulation of the β-amyloid peptide (Aβ) within the brain along with hyperphosphorylated …

APOE interacts with ACE2 inhibiting SARS-CoV-2 cellular entry and inflammation in COVID-19 patients

H Zhang, L Shao, Z Lin, QX Long, H Yuan… - Signal transduction and …, 2022 - nature.com
Apolipoprotein E (APOE) plays a pivotal role in lipid including cholesterol metabolism. The
APOE ε4 (APOE4) allele is a major genetic risk factor for Alzheimer's and cardiovascular …

[HTML][HTML] APOE genotype and cognition in healthy individuals at risk of Alzheimer's disease: A review

MC O'Donoghue, SE Murphy, G Zamboni, AC Nobre… - cortex, 2018 - Elsevier
APOE-ε4 is best known as a risk factor for Alzheimer's disease (AD). Consequently, there is
considerable research interest in understanding whether APOE-ε4 influences cognition in …

Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with Alzheimer's disease: a systematic review and meta-analysis

A Ward, S Crean, CJ Mercaldi, JM Collins, D Boyd… - …, 2012 - karger.com
Background: Population allele frequencies of apolipoprotein E (APOE) vary by geographic
region. The purpose of this study is to summarize and evaluate published estimates for the …

The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity

P Abondio, M Sazzini, P Garagnani, A Boattini, D Monti… - Genes, 2019 - mdpi.com
Human longevity is a complex phenotype resulting from the combinations of context-
dependent gene-environment interactions that require analysis as a dynamic process in a …